RT Journal Article
SR Electronic
T1 Phase I study of ABBV-428, a mesothelin-CD40 bispecific, in patients with advanced solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e002015
DO 10.1136/jitc-2020-002015
VO 9
IS 2
A1 Luke, Jason J
A1 Barlesi, Fabrice
A1 Chung, Ki
A1 Tolcher, Anthony W
A1 Kelly, Karen
A1 Hollebecque, Antoine
A1 Le Tourneau, Christophe
A1 Subbiah, Vivek
A1 Tsai, Frank
A1 Kao, Steven
A1 Cassier, Philippe A
A1 Khasraw, Mustafa
A1 Kindler, Hedy L
A1 Fang, Hua
A1 Fan, Frances
A1 Allaire, Kathryn
A1 Patel, Maulik
A1 Ye, Shiming
A1 Chao, Debra T
A1 Henner, William R
A1 Hayflick, Joel S
A1 McDevitt, Michael A
A1 Fong, Lawrence
YR 2021
UL http://jitc.bmj.com/content/9/2/e002015.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.